{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2020", "item": "https://www.patentleaderboard.com/2020/"}, {"@type": "ListItem", "position": 3, "name": "Pfizer", "item": "https://www.patentleaderboard.com/2020/company/pfizer"}, {"@type": "ListItem", "position": 4, "name": "Benjamin Thuma", "item": "https://www.patentleaderboard.com/2020/inventor/fl:be_ln:thuma-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
BT

Benjamin Thuma — 3 Patents in 2020

Pfizer: 3 patents #36 of 411Top 9%
University of California: 1 patents #314 of 1,821Top 20%
Old Lyme, CT: #3 of 12 inventorsTop 25%
Connecticut: #577 of 4,387 inventorsTop 15%
Overall (2020): #97,542 of 565,922Top 20%
3 Patents 2020

Issued Patents 2020

Showing 1–3 of 3 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
10851367 Tissue-specific genome engineering using CRISPR-Cas9 Spiros Liras, Vincent Mascitti, Jennifer A. Doudna, Romain Rouet 2020-12-01 $390,003,000
10813942 Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR Spiros Liras, Vincent Mascitti 2020-10-27 $309,700,000
10787438 Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors Matthew S. Dowling, Dilinie Fernando, Kentaro Futatsugi, Kim Huard, Thomas Victor Magee +5 more 2020-09-29 $414,122,000